Bluejay Diagnostics, Inc. (BJDX) — 分析师展望 / 分析师共识目标价为. 基于 1 位分析师评级, 共识为 中性 — 1 持有.
分析师预估 每股收益(EPS)为 $-1,584.00 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-42.08 vs 预期 $-1,584.00 (超预期 +97.3%). 2025: 实际 $-15.25 vs 预期 $-512.00 (超预期 +97%). 分析师准确度: 0%.
BJDX 分析师评级
Hold
基于过去3个月内 1 位分析师对 Bluejay Diagnostics, Inc. 的评级
EPS 预测 — BJDX
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$42.08
vs Est –$1,584.00
▲ 3,664.3% off
2025
Actual –$15.25
vs Est –$512.00
▲ 3,257.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — BJDX
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
